Jul 3, 2024, 06:33
MRI PI-RADS Score and Prostate Cancer Active Surveillance Early Biopsy Reclassification
Baris Turkbey, Senior Clinician at the Molecular Imaging Branch at NCI, shared on X:
“Association of Baseline MRI PI-RADS Score With Prostate Cancer Active Surveillance Early Biopsy Reclassification.
- Baseline PI-RADS ≥ 4 lesions were significantly associated with increased risk of biopsy reclassification to >GG2
- Grade group 2 vs 1 was associated with higher reclassification risk (>GG2)
- Increasing age (per 10 years) was linked to higher reclassification risk (>GG2)
Congrats to Kiran Nandalur and Michigan Urological Surgery Improvement Collaborative (MUSIC) investigators for this important work.”
Source: Baris Turkbey/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 8, 2025, 19:42
Feb 8, 2025, 19:39
Feb 8, 2025, 19:31
Feb 8, 2025, 19:23
Feb 8, 2025, 19:19
Feb 8, 2025, 19:10
Feb 8, 2025, 19:05